NIH-funded research R01 grant

Improving opioid access for advanced cancer patients near end of life

Official title: Policies to Inform Safe and Equitable Opioid Access for Patients with Advanced Cancer Near End of Life

Funded at University of Pittsburgh at Pittsburgh · NIH-10878850 · Data updated 2026-11-12

This study looks at how new laws about pain medication affect people with advanced cancer who are close to the end of their lives, especially those who might face extra challenges, like being from low-income backgrounds or living in rural areas, to make sure they can get the pain relief they need safely.

More Advanced Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startJuly 1, 2023
Project endJune 30, 2027
Funding year2024
Award (this year)$399,999
NIH project number5R01HS029170-02
Project IDNIH-10878850 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients with advanced cancer who are experiencing significant pain and are nearing the end of life.

Less likely to help

Patients with early-stage cancer or those not experiencing pain may not receive direct benefits from this research.

What this research studies

This research investigates how state-level opioid policies affect patients with advanced cancer who are nearing the end of life. It aims to understand the impact of recent changes in opioid prescribing laws on these patients, particularly focusing on vulnerable groups such as Black, low-income, elderly individuals, and those living in rural areas. By analyzing over 10 years of claims data, the project seeks to identify ways to ensure safe and equitable access to opioids for those suffering from cancer-related pain. The findings will help inform policies that balance the need for pain management with the prevention of opioid misuse.

Why it matters

Potential benefit: If successful, this research could lead to improved access to necessary pain relief for advanced cancer patients, enhancing their quality of life.

How similar studies have gone: While there has been research on opioid prescribing policies, this specific focus on advanced cancer patients and their unique needs is relatively novel.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Sabik, Lindsay Marie — University of Pittsburgh at Pittsburgh
  • Study coordinator: Sabik, Lindsay Marie

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.